The predictive performance of the continuous CTS5 could not be confirmed on the relative scale (interaction p-value 0.47), although there was a numerical trend favoring additional five years of ET in patients with higher CTS5 values.
← all excerpts
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
2
—
—
The sentences
In the ABCSG-16 cohort, a notable benefit of extending ET was observed in the high-risk group, even though the result did not reach statistical significance.